India's medicinal landscape is witnessing a remarkable rise in drug substance production houses. Fueled by increasing global demand and favorable government guidelines, the Indian API manufacturing sector has arisen as a key contributor to the international medical supply chain. This growth is creating several opportunities for investment and workp